These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 10138581

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pharmacist intervention program focused on i.v. ranitidine therapy.
    Santora J, Kitrenos JG, Green ER.
    Am J Hosp Pharm; 1990 Jun; 47(6):1346-9. PubMed ID: 2368729
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Use of staff pharmacists to reduce the inappropriate use of parenteral histamine-2 antagonist therapy.
    Caldwell RD, Davis SK.
    Hosp Pharm; 1987 Dec; 22(12):1205-9. PubMed ID: 10285375
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The use of intravenous H2-receptor antagonists in a tertiary care hospital.
    Dettmer RM, Riley TH, Byfield F, Green PH.
    Am J Gastroenterol; 1999 Dec; 94(12):3473-7. PubMed ID: 10606306
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Impact of a pharmacy resident on hospital length of stay and drug-related costs.
    Terceros Y, Chahine-Chakhtoura C, Malinowski JE, Rickley WF.
    Ann Pharmacother; 2007 May; 41(5):742-8. PubMed ID: 17440008
    [Abstract] [Full Text] [Related]

  • 11. Automated administration of intermittent intravenous doses.
    Lutomski DM, Schwartz-Fulton J, Rivera JO.
    Am J Hosp Pharm; 1985 Nov; 42(11):2514-7. PubMed ID: 4073071
    [Abstract] [Full Text] [Related]

  • 12. Pharmacist monitoring of QTc interval-prolonging medications in critically ill medical patients: a pilot study.
    Ng TM, Bell AM, Hong C, Hara JM, Touchette DR, Danskey KN, Lindsay TT, Puumala SE.
    Ann Pharmacother; 2008 Apr; 42(4):475-82. PubMed ID: 18319393
    [Abstract] [Full Text] [Related]

  • 13. A practice-based approach for converting from proton pump inhibitors to less costly therapy.
    Lucas LM, Gerrity MS, Anderson T.
    Eff Clin Pract; 2001 Apr; 4(6):263-70. PubMed ID: 11769299
    [Abstract] [Full Text] [Related]

  • 14. Computer program for comparing total costs of intravenous antibiotic regimens.
    Parr MD, Hansen LA, Waite WW, Rapp RP.
    Am J Hosp Pharm; 1986 Sep; 43(9):2189-93. PubMed ID: 3766570
    [Abstract] [Full Text] [Related]

  • 15. Reducing costs by adjusting dosage intervals for intravenous ranitidine.
    Holt RT, Graves LJ, Scheil E.
    Am J Hosp Pharm; 1990 Sep; 47(9):2068-9. PubMed ID: 2220867
    [No Abstract] [Full Text] [Related]

  • 16. Cost of computerized drug interaction screening system.
    Greenlaw CW.
    Am J Hosp Pharm; 1981 Apr; 38(4):521-4. PubMed ID: 7282679
    [Abstract] [Full Text] [Related]

  • 17. Indicators to control drug costs in hospitals.
    Mehl B.
    Am J Hosp Pharm; 1984 Apr; 41(4):667-75. PubMed ID: 6720708
    [Abstract] [Full Text] [Related]

  • 18. Evaluation and financial impact of imipenem/cilastatin dosing in elderly patients based on renal function and body weight.
    Ritchie DJ, Reichley RM, Canaday KL, Bailey TC.
    J Pharm Technol; 1993 Apr; 9(4):160-3. PubMed ID: 10128045
    [Abstract] [Full Text] [Related]

  • 19. A pharmacoeconomic analysis of IV H2-receptor antagonist use in 40 hospitals.
    Segal R, Oh T, Ben-Joseph R, Russell WL.
    Hosp Formul; 1994 May; 29(5):379-82, 388-91. PubMed ID: 10136601
    [Abstract] [Full Text] [Related]

  • 20. Ciprofloxacin use under a reserved drug and stepdown promotion program.
    Frighetto L, Martinusen SM, Mamdani F, Jewesson PJ.
    Can J Hosp Pharm; 1995 Feb; 48(1):35-42. PubMed ID: 10141061
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.